Navigation Links
Published Data Demonstrate Arena Pharmaceuticals' Lorcaserin Has Low Abuse Potential
Date:12/10/2009

vous system, inflammatory and metabolic diseases. Arena's most advanced drug candidate, lorcaserin, is being investigated in a Phase 3 clinical trial program for weight management. Arena has a broad pipeline of novel compounds targeting G protein-coupled receptors, an important class of validated drug targets, which includes compounds being evaluated independently and with partners, including Merck & Co., Inc., and Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Arena Pharmaceuticals® and Arena® are registered service marks of the company. "APD" is an abbreviation for Arena Pharmaceuticals Development.

Forward-Looking Statements

Certain statements in this press release are forward-looking statements that involve a number of risks and uncertainties. Such forward-looking statements include statements about the risk for abuse associated with lorcaserin; the use of abuse liability studies by the FDA and DEA and the significance of such studies in determining post-marketing scheduling and control; the development, advancement, therapeutic indication and use, tolerability, safety, selectivity and efficacy of lorcaserin; lorcaserin's patent coverage; and Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, regulatory authorities may disagree with the assessment of the abuse and other study results or find data from Arena's clinical trials and studies not sufficient for regulatory approval; the timing, success and cost of Arena's lorcaserin program and other of its research and development programs; the timing and ability of Arena to receive regulatory approval for
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
2. Adlyfe Study on the Detection of Misfolded Proteins Published in the Journal Transfusion
3. Nebivolol Lowers Blood Pressure in Mild-to-Moderate Hypertensive Patients as Demonstrated in a Study Published in the Journal of Clinical Hypertension
4. Results from Study Evaluating PROCRIT(R) in Intensive Care Unit Patients Published in New England Journal of Medicine
5. Newly Published Phase II Study Shows the Investigational Drug Vandetanib Prolongs Progression-Free Survival in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
6. Study Published in Endocrinology Reports Potential of Modigene Technology to Extend Duration of Protein Drugs
7. New Data Published in Neurology Show Once-Daily Lamictal XR Significantly Reduced Partial Seizures in Patients with Epilepsy
8. Studies Showing Significant Survival Improvement with Taxotere(R)-based Regimens in the Induction Treatment of Patients with Locally Advanced Head and Neck Cancer are Published in the Same Issue of the New England Journal of Medicine
9. Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
10. UPDATE: Nebivolol Lowers Blood Pressure in African Americans With Stage I-II Hypertension as Demonstrated in a Study Published in the Journal of Clinical Hypertension
11. Tumor Eradication Article Published by Cancer Research
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... July 28, 2015 Codman Neuro*, part of ... a new platform of embolic coils for the treatment ... designed to improve microcatheter stability and provide an optimized ... made here at the Society of NeuroInterventional Surgery (SNIS) ... of framing, filling and finishing coils used during a ...
(Date:7/28/2015)... JOLLA, Calif. , July 28, 2015   ... biopharmaceutical company leading the discovery and development of innovative ... financial results and highlights for the quarter ended June ... U.S. financial markets close. Regulus will ... 4, 2015, at 5:00 pm Eastern Daylight Time to ...
(Date:7/28/2015)... /PRNewswire-USNewswire/ -- Kentucky,s ... after a 2012 law required providers to check a ... yet more evidence that Californians need the same protections, ... Kentucky,s prescription drug abuse legislation took ... 52 percent; opioid prescriptions to doctor-shopping individuals dropped by ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 2Regulus Announces Timing for Second Quarter 2015 Financial Results Webcast and Conference Call 3Study Shows Requiring Prescription Drug Database Use Before Prescribing Powerful, Addictive Medications Critical In Ending Growing Epidemic, says Consumer Watchdog 2
... CIMZIA(R) Data Shows Long-term Improvements in Productivity, Quality of ... at American ... FRANCISCO, Oct. 27 5:00 AM PST -- UCB ... CIMZIA(R),(certolizumab pegol) - the only PEGylated anti-TNF (Tumor Necrosis ...
... As Effective As,Twice-a-Day Linezolid When Used to Treat ... Conn., Oct. 26 Rib-X Pharmaceuticals, Inc.,("Rib-X" or ... development and commercialization of novel antibiotics for the,treatment ... Phase 2 clinical trial with the oral form ...
Cached Medicine Technology:CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 2CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 3CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 4CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 5CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 6CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 7CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 8CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 9CIMZIA(R) (Certolizumab Pegol) Provides Rapid and Sustained Relief from Signs and Symptoms of Rheumatoid Arthritis for Two Years 10Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting 2Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting 3Rib-X Pharmaceuticals Reports Positive Phase 2 Study Results for Next Generation Oxazolidinone at 2008 ICAAC/IDSA Joint Meeting 4
(Date:7/29/2015)... ... ... " mybody ” was featured on NewsWatch as part of its monthly ... impact in their industry. Andrew Tropeano, the host of NewsWatch and business expert, conducted ... designed to strengthen the skin’s defense system from the inside out. , According to ...
(Date:7/29/2015)... , ... July 29, 2015 , ... Indiana is known ... is also the home of Zerorez Indianapolis, which plans to expand across the state. ... “2015 is our second full year in business and we should double our first ...
(Date:7/29/2015)... ... , ... One may not expect to encounter a kickball game or the ... was happening on the campus of Piedmont Crossing , a local 60-acre retirement ... Only , a five-star childcare center which operates on the same campus. As many ...
(Date:7/28/2015)... ... July 29, 2015 , ... ... as a 2015-2016 inductee into its VIP Woman of the Year Circle. She ... nation's leading networking organization exclusively for professional women, boasting more than 700,000 members ...
(Date:7/28/2015)... ... 2015 , ... ProFont is back with a whole new stylized and cursive ... can generate a hand drawn feel all with a click of a mouse. With ... either the upper and lowercase alphabet, special characters, numbers, and stylized compound tools. With ...
Breaking Medicine News(10 mins):Health News:Strengthen the Skin’s Defense System from the Inside Out with mybody 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 2Health News:Zerorez® Announces Plans to Roll Across Indiana—“The Crossroads of America.” 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4Health News:National Association of Professional Women Inducts Susan Bentley, Owner of Women's Wellness Options, Into its VIP Woman of the Year Circle 2Health News:Announcing ProFont Cursive from FCPX Effects developer Pixel Film Studios 2
... of each altered in people with chronic obstructive ... (HealthDay News) -- A disrupted breathing-swallowing pattern may ... obstructive pulmonary disease (COPD) are at increased risk ... moderate to severe COPD show alterations between normal ...
... on the most lethal aspect of cancer will open ... Anderson Cancer Center with support from a highly competitive ... Graduate Program in Cancer Metastasis Research: Bench to Bedside, ... cancer from its original site to other organs. The ...
... Society of Corporate Compliance and Ethics and Health Care ... reports on AIG bonuses it is surprising to learn ... can give and receive and how they can entertain, ... of Corporate Compliance and Ethics (SCCE) and Health Care ...
... over 25% annually, according to Millennium Research GroupWALTHAM, ... Group,s (MRG,s) US Markets for Large-Joint Reconstructive ... the fastest-growing segment of the large-joint reconstructive implant ... growth rate of over 25%. Hip resurfacing ...
... The California Medical Association (CMA) has officially named EMPLOYERS(R) ... insurance specialist (R) , its workers, ... writer of workers, compensation insurance for small businesses and ... and their practices. As part of the agreement, ...
... 26 New findings published in the April issue of ... an important role in promoting heart and bone health. ... Symposium on the role of soy in health promotion and ... November 9-12, 2008."Much progress has been made in understanding the ...
Cached Medicine News:Health News:Swallowing-Breathing Dysfunction Worsens Lung Disorder 2Health News:M. D. Anderson launches graduate program in cancer metastasis 2Health News:Bonuses May be Big but Don't Expect a Lavish Dinner or Gift 2Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 2Health News:Hip Resurfacing Championed as a Bone-Preserving Alternative to Total Hip Replacement 3Health News:California Medical Association Names EMPLOYERS(R) Provider of Choice for its 35,000 Physician Members 2Health News:New Report In The Journal of Nutrition Shows Soy Is Beneficial For Heart and Bone Health 2Health News:New Report In The Journal of Nutrition Shows Soy Is Beneficial For Heart and Bone Health 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: